+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Mutation and methylation status of p53 gene promoter in human breast tumours



Mutation and methylation status of p53 gene promoter in human breast tumours



Tumour Biology 20(6): 341-346



Few reports are available on mutations in the promoter of tumour suppressor genes like p16, WT1 and Rb in cancers. However, the involvement of p53 promoter in cancers is not clearly known. Further, methylation of CpG sites is a major contributor of mutations in several genes. So an attempt has been made to determine the mutation and methylation status of p53 promoter in breast tumours. Results have demonstrated absence of mutations and deletions in p53 promoter, leading us to conclude that mutation of p53 promoter is probably not a significant factor in breast tumorigenesis. Methylation analysis has shown that the CCGG sites in the p53 promoter are unmethylated unlike that of its exons. Further, it has been shown that there is no change in the methylation profile of the CCGG sites in breast tumours. However, such studies are to be conducted in different types of tumours to define the role of p53 promoter mutation and methylation in the process of tumorigenesis.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011029022

Download citation: RISBibTeXText

PMID: 10567880

DOI: 10.1159/000030098


Related references

CpG island methylation status and mutation analysis of the RB1 gene essential promoter region and protein-binding pocket domain in nervous system tumours. British Journal of Cancer 88(1): 109-114, 2003

Methylation in the p53 promoter is a supplementary route to breast carcinogenesis: correlation between CpG methylation in the p53 promoter and the mutation of the p53 gene in the progression from ductal carcinoma in situ to invasive ductal carcinoma. Laboratory Investigation; a Journal of Technical Methods and Pathology 81(4): 573-579, 2001

Promoter Methylation Status of Breast Cancer Susceptibility Gene 1 and 17 Beta Hydroxysteroid Dehydrogenase Type 1 Gene in Sporadic Breast Cancer Patients. International Journal of Breast Cancer 2016: 9545241, 2016

Study on the status of methylation of Rb gene promoter in human esophageal cancer and effect of NMBzA on Rb gene promoter in monkey esophageal epithelium. Zhonghua Zhong Liu Za Zhi 20(6): 412-414, 1998

Research on promoter region methylation status of tumor repressor gene P16 in human hepatocellular carcinoma by using methylation sensitive restriction enzyme and semi-nested PCR assay. Sichuan Da Xue Xue Bao. Yi Xue Ban 38(1): 53-56, 2007

Promoter methylation status of the FHIT gene and Fhit expression: association with HER2/neu status in breast cancer patients. Oncology Reports 30(5): 2270-2278, 2013

Evaluation of Methylation Status in the 5'UTR Promoter Region of the DBC2 Gene as a Biomarker in Sporadic Breast Cancer. Cell Journal 14(1): 19-24, 2012

P16 (INK4a, MTS-1) gene polymorphism and methylation status in human pituitary tumours. Clinical Endocrinology 51(3): 317-325, 1999

Promoter Methylation Status Modulate the Expression of Tumor Suppressor (RbL2/p130) Gene in Breast Cancer. Plos one 10(8): E0134687, 2015

Endometrial tumour BRAF mutations and MLH1 promoter methylation as predictors of germline mismatch repair gene mutation status: a literature review. Familial Cancer 13(1): 1-12, 2014

Promoter methylation reduces C/EBPdelta (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors. Breast Cancer Research and Treatment 95(2): 161-170, 2006

Promoter methylation reduces C/EBP delta (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors. Breast Cancer Research and Treatment 95(2): 161-170, 2006

Methylation status of the Ep-CAM promoter region in human breast cancer cell lines and breast cancer tissue. Cancer Letters 246(1-2): 253-261, 2007

Methylation status of p16 in breast cancer cell lines, normal breast tissue, breast tumours and lymphocytes. British Journal of Cancer 83(Suppl. 1): 55, 2000